Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer
Titel:
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer
Auteur:
Cinieri, Saverio Chan, Arlene Altundag, Kadri Vandebroek, An Tubiana-Mathieu, Nicole Barnadas, Agusti Dodyk, Patricia Lazzarelli, Silvia Botha, Michiel Rauch, Daniel Villanova, Gustavo Coskun, Ugur